21 results match your criteria: "Bastian Voice Institute[Affiliation]"
Otolaryngol Head Neck Surg
June 2023
Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
The North American Airway Collaborative (NoAAC) previously published a 3-year multi-institutional prospective cohort study showing variation in treatment effectiveness between 3 primary surgical techniques for idiopathic subglottic stenosis (iSGS). In this report, we update these findings to include 5 years of data evaluating treatment effectiveness. Patients in the NoAAC cohort were re-enrolled for 2 additional years and followed using the prespecified published protocol.
View Article and Find Full Text PDFAm J Gastroenterol
September 2022
Bastian Voice Institute, Downers Grove, Illinois USA.
OTO Open
March 2022
Bastian Voice Institute, Downers Grove, Illinois, USA.
OTO Open
December 2021
Bastian Voice Institute, Downers Grove, Illinois, USA.
Objective: To evaluate a novel treatment for sensory neuropathic cough (SNC): topical capsaicin.
Study Design: Retrospective review.
Setting: Tertiary care laryngology clinic.
Otolaryngol Head Neck Surg
December 2022
Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Objective: Surgical procedures that render patients acutely aphonic can cause them to experience significant anxiety and distress. We queried patient perceptions after tracheostomy or laryngectomy and investigated whether introducing augmentative technology was associated with improvement in patient-reported outcomes.
Methods: Participants included hospitalized patients who acutely lost the ability to speak due to tracheostomy or total laryngectomy from April 2018 to December 2019.
Ann Otol Rhinol Laryngol
December 2021
Bastian Voice Institute, Downers Grove, IL, USA.
Objective: To determine if brincidofovir, an oral analog of cidofovir that achieves high tissue levels of the active metabolite with low systemic toxicity, has an observable effect on HPV-related disease of the larynx.
Methods: Two patients with laryngeal recurrent respiratory papillomatosis (one each of genotypes 6 and 11) and 1 with recurring aryepiglottic fold (genotype 16) received oral brincidofovir according to protocol. Close-range videoendoscopic examinations were done during and after the study period to observe disease behavior in the absence of other interventions, and after subsequent surgical intervention.
Ann Otol Rhinol Laryngol
October 2021
Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Objectives: To examine whether social determinants of health (SDH) factors are associated with time to diagnosis, treatment selection, and time to recurrent surgical intervention in idiopathic subglottic stenosis (iSGS) patients.
Methods: Adult patients with diagnosed iSGS were recruited prospectively (2015-2017) via clinical providers as part of the North American Airway Collaborative (NoAAC) and via an online iSGS support community on Facebook. Patient-specific SDH factors included highest educational attainment (self-reported), median household income (matched from home zip code via U.
OTO Open
February 2021
Bastian Voice Institute, Downers Grove, Illinois, USA.
Objective: To report the efficacy and safety of electromyography-guided percutaneous botulinum toxin injection into the cricopharyngeus muscle in an office setting for treatment of the inability to belch and associated symptoms caused by retrograde cricopharyngeus dysfunction (R-CPD).
Study Design: Retrospective case series of treated patients.
Setting: Tertiary care laryngology clinic.
OTO Open
June 2020
Bastian Voice Institute, Downers Grove, Illinois, USA.
Objectives: To report the percentage of patients with symptom relief 6 or more months after botulinum toxin injection into the cricopharyngeus muscle for retrograde cricopharyngeus dysfunction (R-CPD).
Study Design: Retrospective case series of consecutively treated patients.
Setting: Tertiary care laryngology clinic.
Otolaryngol Head Neck Surg
October 2020
Bastian Voice Institute, Downers Grove, Illinois, USA.
Objective: To define the human papillomavirus (HPV) subtypes seen in a large adult population with traditionally defined recurrent respiratory papillomatosis.
Study Design: Retrospective review.
Setting: Tertiary care laryngology practice.
OTO Open
April 2020
Bastian Voice Institute, Downers Grove, Illinois, USA.
PLoS One
June 2020
Merck & Co., Inc., (MSD), North Wales, Pennsylvania, United States of America.
Background: Recurrent respiratory papillomatosis (RRP) is characterized by repeated formation of papillomas in the respiratory tract and is caused by human papillomavirus (HPV) types 6 and 11. Women with genital HPV infection are slow to develop weak humoral immunity, but respond robustly to the HPV vaccine. We wondered if people with RRP had a similar immune response.
View Article and Find Full Text PDFJAMA Otolaryngol Head Neck Surg
March 2020
Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor.
Importance: The use of intralesional cidofovir injections for recurrent respiratory papillomatosis (RRP) remains controversial owing to concern regarding the risks of its use, including increased risk of dysplasia or carcinogenesis.
Objective: To describe the rates of dysplasia, development of malignant lesions, and adverse events associated with use of intralesional cidofovir injections as adjuvant treatment for RRP compared with patients treated without adjuvant cidofovir.
Design, Setting, And Participants: In this case series performed at a tertiary care referral center, review of electronic medical records on all adult and pediatric patients (N = 154) treated for RRP with adequate follow-up from January 1, 2000, to December 31, 2016, was performed.
JAMA Otolaryngol Head Neck Surg
January 2020
Department of Otolaryngology-Head and Neck Surgery, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio.
Importance: Surgical treatment comparisons in rare diseases are difficult secondary to the geographic distribution of patients. Fortunately, emerging technologies offer promise to reduce these barriers for research.
Objective: To prospectively compare the outcomes of the 3 most common surgical approaches for idiopathic subglottic stenosis (iSGS), a rare airway disease.
OTO Open
March 2019
Bastian Voice Institute, Downers Grove, Illinois, USA.
Objective: To propose and test the validity of a new syndrome called retrograde cricopharyngeus dysfunction (R-CPD) that explains inability to belch and the associated symptoms of loud gurgling noises, chest and abdominal pain/distention, and excessive flatulence, as well as to report the results of botulinum toxin (BT) injection into the cricopharyngeus muscle (CPM) for both diagnosis and treatment of R-CPD.
Study Design: To develop a case series of consecutive patients matched to the syndromic features of R-CPD, inject the CPM with BT as a concurrent diagnostic and therapeutic maneuver, and assess results.
Setting: Bastian Voice Institute (Downers Grove, Illinois).
PLoS One
February 2020
Departments of Microbiology and Immunology, and Otolaryngology-Head and Neck Surgery and Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
Background: Recurrent Respiratory Papillomatosis (RRP) is a rare disease characterized by the growth of papillomas in the airway and especially the larynx. The clinical course is highly variable among individuals and there is poor understanding of the factors that drive an aggressive vs an indolent course.
Methods: A convenience cohort of 339 affected subjects with papillomas positive for only HPV6 or HPV11 and clinical course data available for 1 year or more, from a large multicenter international study were included.
PeerJ
March 2015
Bastian Voice Institute , Downers Grove, IL , USA ; Department of Otolaryngology, Head and Neck Surgery, Loyola University Medical Center, Maywood, IL , USA.
Objective. This study sought to: (1) quantify response rate and efficacy of amitriptyline, desipramine, and gabapentin in treating sensory neuropathic cough; and (2) describe an efficient treatment protocol. Study Design.
View Article and Find Full Text PDFMol Genet Genomic Med
May 2014
Departments of Neurology and Anatomy & Neurobiology, University of Tennessee Health Science Center Memphis, Tennessee, 38163.
Although coding variants in THAP1 have been causally associated with primary dystonia, the contribution of noncoding variants remains uncertain. Herein, we examine a previously identified Intron 1 variant (c.71+9C>A, rs200209986).
View Article and Find Full Text PDFNeurology
April 2014
From the Departments of Neurology and Anatomy & Neurobiology (S.R.V., J.X., M.S.L.), University of Tennessee Health Science Center, Memphis, TN; Bastian Voice Institute (R.W.B.), Downers Grove, IL; Clinic for Child Neurology and Psychiatry (D.M.), Medical Faculty University of Belgrade, Serbia; and New York Center for Voice and Swallowing Disorders (A.B.), NY.
Objective: To determine the contribution of TUBB4A, recently associated with DYT4 dystonia in a pedigree with "whispering dysphonia" from Norfolk, United Kingdom, to the etiopathogenesis of primary dystonia.
Methods: High-resolution melting and Sanger sequencing were used to inspect the entire coding region of TUBB4A in 575 subjects with primary laryngeal, segmental, or generalized dystonia.
Results: No pathogenic variants, including the exon 1 variant (c.
Otolaryngol Head Neck Surg
July 2006
Loyola University Medical Center, and Bastian Voice Institute, 3010 Highland Parkway, Downers Grove, IL 60515, USA.
Objective: To describe our experience with chronic sensory neuropathic cough and its response to amitriptyline in a first group of patients.
Study Design And Setting: A prospective cohort of patients is described in detail. Each was referred to an academic laryngological practice after extensive prior negative workup for cough and failure to respond to various treatments.
Otolaryngol Clin North Am
February 2004
Bastian Voice Institute, 3010 Highland Parkway, Suite 550, Downers Grove, IL 60515, USA.
Vocal fold paralysis is regarded as a sign of other pathologic findings until investigation has proven that there is no lesion to explain the paralysis. We have outlined a cost-effective and time- and labor-efficient method for the clinical evaluation of vocal fold paralysis, including a focused history; vocal capability assessment to find deficits in the function of palate,pharynx, and larynx: and, finally, an intense examination under topical anesthesia to demonstrate these deficits. In essence, it is the endoscopic version of a radiographic study from the skull base through the aortic arch.
View Article and Find Full Text PDF